Imaging and Biomarker Evaluation of Hepatic Stiffness in Children Enrolled in the Fontan Udenafil Exercise Longitudinal Study
Latest Information Update: 07 Nov 2022
At a glance
- Drugs Udenafil (Primary)
- Indications Liver disorders
- Focus Therapeutic Use
- Acronyms FALD
- Sponsors Mezzion
- 22 Nov 2020 Planned End Date changed from 31 Dec 2020 to 31 Aug 2021.
- 22 Nov 2020 Planned primary completion date changed from 30 Jul 2020 to 30 Jun 2021.
- 11 Jan 2020 Status changed from recruiting to active, no longer recruiting.